Differentiating MODY from other types of diabetes has major implications; it prevents unnecessary lifelong insulin use, allows cost-effective sulfonylurea therapy, facilitates early detection and management of diabetes in family members, and enables genetic counseling [2]. The gene discussed is INS; the disease is MODY.